Latest News
- The Rare Cancer EU Access Index Survey: We need your input from the Sarcoma-Community...
- “My GIST Companion” - app to support adherence in GIST patients
- Genetic Risk Factor for Chordoma Identified
- EMA will review a marketing authorization application for Masitinib in the treatment of Imatinib resistant GIST
- EMA will review a marketing authorization application for Masitinib in the treatment of Imatinib resistant GIST
Latest Events
- 29.05.2013 - 31.05.2013 26th EMSOS Annual ...
- 31.05.2013 - 04.06.2013 ASCO Annual Meetin...
- 30.10.2013 - 05.11.2013 CTOS Annual Meetin...
Our visitors are from ...
Top 5:
70312 visits from 136 countries
 | 8% | Ukraine (5738) |
 | 5% | Germany (3793) |
 | 4% | Netherlands (2851) |
 | 4% | Russian Federation (2833) |
 | 4% | United Kingdom (2465) |
| Gallery | Description | ||
|---|---|---|---|
|
3rd SPAEN Conference 2012, Florence/Italy | This year, roughly 100 participants from 20 different countries attending the 3rd SPAEN Annual Conference documented the... | |
|
2nd SPAEN Annual Conference 2011 in Berlin/Germany | Nearly 100 participants who attended the 2nd SPAEN Annual Conference for organizations representing patients with Sarcom... | |
|
New Horizons in Treating CML and GIST 2011 | On 13-15 May 2011, the 9th International Conference for Organisations representing GIST and CML patients took place in A... | |
|
1st SPAEN Annual Conference 2010 | The 1st SPAEN Annual Conference for Organizations Representing Patients with Sarcomas, GIST or Desmoid Tumours was held... | |
